Outsourcing in silico predictive toxicology: technologies, markets and paradigms
This article provides a brief overview of the current and anticipated paradigms in drug development and examines how the adoption of breakthrough in silico predictive toxicology can play a key role in making the transition between the two.
Spring 2010
Tackling toxicity
Dr. Marc Conti, Corine Matar, Alexandre Ismail and Josua Franck at BioQuanta examine the problems facing new technologies in early toxicity assessment.
Integrating computational methods and drug discovery - avoiding pitfalls in chemical space
Pr. Philippe Manivet and Alexandre Ismail discuss the advantages and limitations of the integration of computational methods into the drug discovery process involving the use of a reliable in silico screening method.